Cloud Computing - Current scenario, trends & Key players

Published: September 2011

No. of Pages: 155
Price: $ 1199


Cloud computing is emerging as a major disruptive force for both IT vendors and users as companies globally strive to reduce cost of ownership for IT infrastructure. However the term “cloud computing” means many things and different service layers (Infrastructure, Platform, Software) are deployed across organizations based on customer needs. There is plethora of service providers with expertise in different service layers of the cloud. In addition to the different layers of services in cloud computing there are different technological concepts like Grid computing, Virtual computing, etc. that need to be well understood by IT managers and end users alike before signing up with a service provider. Last but not least there isMobile cloud computing which is gaining tremendous traction thanks to advances in smart phones and tablet devices. This report Cloud Computing - Current scenario, trends & Key players provides a comprehensive analysis of cloud computing services, market segmentation, technology basics, trends, key players and challenges for cloud deployment in enterprise IT.

Key topics covered
• Cloud computing concepts, service layers, public vs. private clouds, deployment technologies
• Segmentation of cloud services
• Major vendors across the segments
• Details on high performance utility computing (Hadoop, MapReduce)
• Analyzes how cloud computing has been growing and predicts how it will impact IT in
• Explains how public clouds are converging and becoming more business-centric, and how private and hybrid clouds are emerging.
• Explains the current trends and 2011 predictions for IaaS, SaaS, and PaaS.

Browse All: IT Market Research Reports

Highlights
In this tough economic times companies are striving to reduce costs and focus on core competencies. Many firms are realizing IT costs can be reduced by moving to cloud services offered by multitude of service providers. However organizations, users and providers have yet to figure out how to take advantage of cloud computing's offerings. This report is meant to be a blueprint for senior executives to navigate through the complexities of virtual cloud environment.

Your key questions answered
• What the are key services and underlying technologies in cloud computing ?
• Who are the major players in each of the cloud segment ?
• What are the key trends in cloud computing and how will they change in the next 3-5 years
• Should I move to public or private cloud and what are the differences ?
• What are some of the key challenges/hurdles for deployment of cloud computing ?
• What is high performance cloud computing ?
• What are some recommendations for service providers ?

European Point of Care Diagnostic Testing Markets

Published: September 2011
No. of Pages: 179
Price: $ 3400

Point of care testing (POCT) enables diagnostic tests to be performed rapidly while the patient remains at the point of care facility, such as a hospital, health clinic, doctor's office or another near-patient venue. POCT is rapidly being recognized as a method of providing the results of the diagnostic tests immediately, rather than waiting hours or even days for outside lab results to arrive, thus improving patient outcomes. This report analyzes the European market for POCT products, a major component of the overall European in vitro diagnostics (IVD) category. This study reviews in detail the key sub-segments of the point of care diagnostics market including: blood glucose, blood gas and electrolytes, rapid coagulation, cardiac markers, substance abuse, infectious diseases, urine strip, pregnancy, fecal occult, cholesterol, and many others. For each of the individual sub-segments, this study examines the key market drivers and restraints, as well as evaluates the latest technological advances. 

Browse All: Healthcare Market Research Reports

The key feature of the review is a detailed analysis of the revenues, market growth rates and market share for the European market and for each of the selected geographic regions, which include: France, Germany, Italy, Spain, the U.K., the Benelux countries, Scandinavia and the Rest of Europe (ROE). The analysis surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the European market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included. 

Picture Archiving and Communications Systems (PACS)

Published: September 2011
No. of Pages: 298
Price: $ 3400

During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonance imaging (MRI) emerged, bringing new diagnostic information at the cellular level. X-ray morphed from analog films to digital, and virtually all medical images became "soft" files on the electronic networks. As imaging departments in healthcare facilities have migrated from film to digital, the display and storage systems have had to migrate too. These new digital imaging storage and display systems are called picture archiving and communication systems (PACS).

Browse All: Pharmaceuticals Market Research Reports

Most PACS handle images from various medical imaging instruments, including ultrasound, MRI, positron emission tomography (PET), CT, endoscopy, mammograms, etc. The focus of this TriMark Publications report is to analyze and describe the PACS market segments. PACS market penetration in the U.S. healthcare space has been significant, at almost 90%. A PACS network typically consists of a central server that stores a database containing the images connected to one or more clients via a local area network (LAN) or a wide area network (WAN) that provides or utilizes the images. More and more PACS utilize Internet-based technologies as their means of communication. This allows remote viewing and diagnosis with implications for both civilian and military healthcare facilities. Since radiology departments dominate the production of images, interconnections with radiology information systems (RIS) are also looked at in this study.

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

Published: September 2011

No. of Pages: 343

Price: $ 3400

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for early detection and screening tests for diseases such as breast, colon, ovarian and lung cancer. In addition, diagnostic measurement of cancer disease progression is essential to successful disease management. For these reasons, development of new and effective biomarkers for cancer detection and diagnosis is central to the cancer problem. 

Browse All: Pharmaceuticals Market Research 

The use of nucleic acid biomarker diagnostics have begun to answer these questions. Protein biomarkers are also useful. The purpose of this TriMark Publications report is to describe the specific segment of the cancer diagnostics market which develops new biomarker technology platforms for diagnosing and treating cancer. Biomarkers are useful in following the course of cancer and evaluating which therapeutic regimes are most effective for a particular type of cancer, as well as determining long-term susceptibility to cancer or recurrence. This study Biomarker Technology Platforms for Cancer Diagnoses and Therapies particularly examines those clinical measurement devices, and their reagents and supplies, which are meant to be used in hospitals, clinics, commercial laboratories and doctor’s offices to diagnose and monitor cancer. The examination also provides an in-depth discussion of the application of biomarkers in developing novel targeted cancer therapeutics, their predication response and efficacy, as well as their use in diagnosis of cancer.